通心络胶囊治疗椎基底动脉供血不足50例临床疗效评价

目的:观察通心络胶囊治疗椎基底动脉供血不足的临床疗效.方法:将118例椎基底动脉供血不足患者随机分为治疗组和对照组,治疗组口服通心络胶囊,对照组口服复方丹参片,均连续治疗8周,治疗前和治疗8周后予评分,并做经颅多普勒超声和血液流变学检查.结果:治疗组降低血黏度、增加椎动脉和基底动脉平均血流速度均较对照组明显(P＜0.05);治疗组改善临床症状的总有效率为96.0%,对照组为85.3%,前者明显高于后者(P＜0.05).结论:通心络胶囊对椎基底动脉供血不足具有良好的治疗作用.

Clinical evaluation of therapeutic effects on tongxinluo capsule in 50 patients with blood supply insufficiency of vertebrobasilar artery

Objective: To evaluate the therapeutic effects on Tongxinluo capsule in patients with vertebrobasilar ischemia.Methods: 100 cases of the patients suffering vertebrobasilar ischemia were randomly divided into treatment group and control group.The patients in treatment group were treated with Tongxinluo capsule,and those in control group were given with Compound Danshen by oral administration for the period of 8 weeks.The therapeutic effects were compared between two groups by skull Dopplar ultrasound and blood rheologic examination,before and after 8 weeks treatment.Results: The effects of decreasing of plasma adhesion and increasing of VM in vertebrobasilar artery were significant in treatment group than those in control group.The total effective rate of improving symptom was 96% in treatment group and 86% in control group respectively(P<0.5).Conclusion: Tongxinluo capsule has better therapeutic effects for the patients with vertebrobasilar ischemia.